OPN promotes the aggressiveness of non-small-cell lung cancer cells through the activation of the RON tyrosine kinase

Osteopontin (OPN) is identified as a diagnostic and prognostic biomarker of tumor progression and metastasis. In non-small-cell lung cancer (NSCLC), the functions of OPN have not been well characterized. The current study sought to investigate the clinical implications of OPN expression in NSCLC and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Chengcheng, Cui, Yuxin, Chang, Siyuan, Huang, Jing, Birkin, Emily, Hu, Mu, Zhi, Xiuyi, Li, Wenbin, Zhang, Lijian, Cheng, Shan, Jiang, Wen G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889187/
https://www.ncbi.nlm.nih.gov/pubmed/31792339
http://dx.doi.org/10.1038/s41598-019-54843-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889187/
https://www.ncbi.nlm.nih.gov/pubmed/31792339
http://dx.doi.org/10.1038/s41598-019-54843-2

Ejemplares similares